Co-stimulation and co-inhibition: Equal partners in regulation

Scandinavian Journal of Immunology

Volumn 43, Issue 6, 1996, Pages 597-603

  Sinclair, N R StC ^a   Anderson, C C ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR; T LYMPHOCYTE RECEPTOR;

AUTOIMMUNITY; ETIOLOGY; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0029886244     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1996.d01-267.x     Document Type: Review

References (78)

1. Burnet FM. A modification of Jerne's theory of antibody production using the concept of clonal selection. Aust J Sci 1957;20:67-73.
2. Mueller DL, Jenkins MK, Schwartz RH. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Ann Rev Immunol 1989;7:445-80.
3. Avrameas S. Natural autoantibodies: from 'horror autotoxicus' to 'gnothi seauton'. Immunol Today 1991;12:154-9.
4. Coutinho A. The network theory, 21 years later. Scand J Immunol 1995;42:3-8.
5. Clark EA, Ledbetter JA. How B and T cells talk to each other. Nature 1994;367:425-8.
6. Armitage RJ, Alderson MR. B-cell stimulation. Curr Opin Immunol 1995;7:243-7.
7. Wu Y, Xu J, Shinde S et al. Rapid induction of a novel constimulatory activity on B cells by CD40 ligand. Current Biology 1995;5:1303-11.
8. Kündig TM, Bachmann MF, DiPaolo C et al. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science 1995;268:1343-7.
9. Hajnoczky G, THomas AP. The inositol trisphosphate calcium channel is inactivated by inositol trisphosphate. Nature 1994; 370:474-7.
10. Suter PS, Suter S, Roessler JS, Parker KL, Armstrong CA, Powers JC. Spatial-frequency-tuned channels in early infancy: VEP evidence. Vision Res 1994;34:737-45.
11. Tykocinski ML, Kaplan DR. Prospects for anti-rejection therapies based upon CD8-dependent immunoregulation. Kidney Int Suppl 1993;39:S120-3.
12. Sinclair NRStC, Panoskaltsis. The immunoregulatory apparatus and autoimmunity. Immunol Today 1988;9:260-5.
13. Gergely J, Rozsnyay Z, Sarmay G. New aspects of FcγRII-mediated B-cell inhibition: switch of FcγRIIb isoforms depends on B-cell activation. The Immunologist 1994;2:77-81.
14. Sinclair NRStC, Panoskaltsis A. Interference with Fc signals increases an antibody response by T-cell-deprived cultures to a T-dependent antigen. Cell Immunol 1987;107:465-70.
15. Panoskaltsis A, Sinclair NRStC. Rheumatoid factor blocks regulatory Fc signals. Cell Immunol 1989;123:177-88.
16. Ravetch JV. Fc receptors: rubor redux. Cell 1994;78:553-60.
17. Fridman WH, Bonnerot C, Daëron M, Amigorena S, Teillaud J-L, Sautes C. Structural bases of Fcγ receptor functions. Immunol Rev 1992;125:49-76.
18. Hulett MD, Hogarth PM. Molecular basis of Fc receptor function. Adv Immunol 1994;57:1-127.
19. 2+ signaling and desensitization in B Cells. J Immunol 1990;144: 4147-55.
20. Borel Y, Golan DT, Kilham L, Borel H. Carrier determined tolerance with various subclasses of murine myeloma IgG. J Immunol 1976;116:854-8.
21. Borel Y, Fritsche R, Borel H et al. Food allergens transformed into tolerogens. Int Arch Allergy Immunol 1995;107:264-7.
22. Diegel ML, Rankin BM, Bolen JB, Dubois PM, Kiener PA. Cross-linking of Fcγ receptor to surface immunoglobulin on B cells provides an inhibitory signal that closes the plasma membrane calcium channel. J Biol Chem 1994;269:11409-16.
23. Amigorena S, Bonnerot C, Drake JR et al. Cytoplasmic domain heterogeneity and functions of IgG Fc Receptors in B lymphocytes. Science 1992;256:1808-12.
24. Choquet D, Ku G, Cassard S et al. Different patterns of calcium signaling triggered through two components of the B lymphocyte antigen receptor. J Biol Chem 1994;269:6491-7.
25. Muta T, Kurosaki T, Misulovin Z, Sanchez M, Nussenzweig MC, Ravetch JV. A 13-amino-acid motif in the cytoplasmic domain of FcγRIIB modulates B-cell receptor signalling. Nature 1994;368:70-3.
26. D'Ambrosio D, Hippen KL, Minskoff SA et al. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by FcγRIIB1. Science 1995;268:293-7.
27. Rankin BM, Yocum SA, Mittler RS, Kiener PA. Stimulation of tyrosine phosphorylation and calcium mobilization by Fcγ receptor cross-linking: regulation by the phosphotyrosine phosphatase CD45. J Immunol 1993;150:605-16.
28. George A, Rath S, Shroff KE, Wang M, Durdik JM. Ligation of CD45 on B cells can faciliate production of secondary Ig isotypes. J Immunol 1994;152:1014-21.
29. Law C-L, Clark EA. Cell-cell interactions that regulate the development of B-lineage cells. Curr Opin Immunol 1994;6: 238-47.
30. Yeung RS-M, Penninger J, Mak TW. T-cell development and function in gene-knockout mice. Curr Opin Immunol 1994; 6:298-307.
31. Doody GM, Justement LB, Delibrias CC et al. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP. Science 1995;269:242-4.
32. Campbell M-A, Klinman NR. Phosphotyrosine-dependent association between CD22 and protein tyrosine phosphatase 1C. Eur J Immunol 1995;25:1573-9.
33. O'Garra A, Murphy K. Role of cytokines in determining T-lymphocyte function. Curr Opin Immunol 1994;6:458-66.
34. Liu Y, Janeway CA. Interferon γ plays a critial role in induced cell death of effector T cell: a possible third mechanism of self-tolerance. J Exp Med 1990;172:1735-9.
35. O'Garra A, Rigley KP, Holman M, McLaughlen JB, Klaus GGB. B-cell stimulatory factor-1 reverses Fc receptor-mediated inhibition of B-lymphocyte activation. Proc Natl Acad Sci USA 1987;84:6254-8.
36. Phillips NE, Gravel KA, Tumas K, Parker DC. IL-4 (B cell stimulatory factor 1) overcomes Fcγ receptor-mediated inhibition of mouse B lymphocyte proliferation without affecting inhibition of c-myc mRNA induction. J Immunol 1988;141: 4243-9.
37. Klaus SJ, Phillips NE, Parker DC. Effects of IL-4 and Fcγ receptor II engagement on Erg-1 expression during stimulation of B lymphocytes by membrane immunoglobulin crosslinking. Mol Immunol 1993;30:1553-8.
38. Nagata S, Fas and fas ligand: a death factor and its receptor. Adv Immunol 1994;57:129-44.
39. Dhein J, Walczak H, Bäumier C, Debatin K-M, Krummer PH. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995;373:438-41.
40. Brunner T, Mogil RJ, LaFace D et al. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 1995;373:441-4.
41. Ju ST, Panka DJ, Cui H et al. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995;373:444-8.
42. Boise L, Minn A, Noel P et al. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL. Immunity 1995;3:87-98.
43. Vella A, McCormack J, Linsley P, Kappler J, Marrack P. Lipopolysaccharide interferes with the induction of peripheral T cell death. Immunity 1995;2:261-70.
44. Rothstein T, Wang J, Panka D et al. Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 1995;374:163-5.
45. + T cells. Nature 1995;376:181-4.
46. Gribben JG, Freeman GJ, Boussiotis VA et al. CTLA4 mediates antigen-specific apoptosis of human T cells. Proc Natl Acad Sci USA 1995;92:811-15.
47. Anderson CC, Rahimpour R, Sinclair NRStC. Lipopolysaccharide-induced IgM production is not suppressed by antigen receptor ligation in B cells from some autoimmune strains of mice. Immunol Res 1994;13:10-20.
48. Anderson CC, Cairns E, Rudofsky UH, Sinclair NRStC. Defective antigen-receptor-mediated regulation of immunoglobulin production in B cells from autoimmune strains of mice. Cell Immunol 1995;164:141-9.
49. Fleming TJ, Malek TR. Multiple glycosylphosphatidylinositol-anchored Ly-6 molecules and transmembrane Ly-6E mediate inhibition of IL-2 production. J Immunol 1994;153:1955-62.
50. Bretscher PA, Cohn M. A theory of self-nonself discrimination. Science 1970;169:1042-9.
51. Ohashi PS. Ignorance is bliss. The Immunologist 1994;2:87-92.
52. Rathmell JC, Goodnow CC. The Fas track. Curr Biol 1995;5: 1218-21.
53. Núñez G, Merino R, Grillot D, Gonzálex-García M. Bcl-2 and Bcl-x: regulatory switches in lymphoid death and survival. Immunol Today 1994;15:582-8.
54. Heyman B, Nose M, Weigle WO. Carbohydrate chains on IgG2b: a requirement for efficient feedback immunosuppression. J Immunol 1985;134:4018-23.
55. Mizuochi T, Hamako J, Nose M, Titani K. Structural changes in the oligosaccharide chains of IgG in autoimmune MRL/Mp-lpr/lpr mice. J Immunol 1990;145:1794-8.
56. Bond A, Cooke A, Hay FC. Glycosylation of IgG, immune complexes and IgG subclasses in the MRL-lpr/lpr mouse model of rheumatoid arthritis. Eur J Immunol 1990;20:2229-33.
57. Rook GAW, Stanford JL. Slow bacterial infections or autoimmunity? Immunol Today 1992;13:160-4.
58. 2 and autoantibody production in patients with cold agglutination. Blood 1995;85: 548-51.
59. Boros P, Chen J, Bona C, Unkeless JC. Autoimmune mice make anti-Fcγ receptor antibodies. J Exp Med 1990;171:1581-95.
60. Sawchuk DJ, Mahmoudi M, Cairns E, Sinclair NRStC. Non-synonymous mutations in a Fc-receptor structural gene in NZB mice. Immunogenetics 1996;43:112-13.
61. Uher F, Dickler HB. Independent ligand occupancy and cross-linking of surface Ig and Fcγ receptors downregulates B-lymphocyte function. Evalution in various B-lymphocyte populations. Mol Immunol 1986;23:1177-81.
62. Brandon EP, Idzerda RL, McKnight GS. Targeting the mouse genome: a compendium of knockouts (part I). Current Biology 1995;5:625-34.
63. Brandon EP, Idzerda RL, McKnight GS. Targeting the mouse genome: a compendium of knockouts (part II). Current Biology 1995;5:758-65.
64. Brandon EP, Idzerda RL, McNight GS. Targeting the mouse genome: a compendium of knockouts (part II). Current Biology 1995;5:873-81.
65. Ferber IA, Brocke S, Tayler-Edwards C et al. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 1996; 156:5-7.
66. Duong TT, Finkelman FD, Singh B, Strejan GH. Effect of anti-interferon-gamma monoclonal antibody treatment on the development of experimental allergic encephalomyelitis in resistant mouse strains. J Neuroimmunol 1994;53:101-7.
67. Sinclair NRStC. Clonalism - the myth? Autoimmunity 1990; 6:131-42.
68. Sinclair NRStC. The trouble with transgenic mice. Immunol Cell Biol 1995;73:169-73.
69. Hivroz C, Roberts A, Debatin K, Fischer A. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995;268:1347-9.
70. Fisher G, Rosenberg F, Straus S et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995;81:935-46.
71. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ. CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab 1995;80:41-5.
72. Waterhouse P, Penninger JM, Timms E et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270:1995;985-8.
73. Perrin PJ, Scott D, Quigley L et al. Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. J Immunol 1995;154:1481-90.
74. Smathers PA, Steinberg BJ, Reeves JP, Steinberg AD. Effects of polyclonal immune stimulators upon NZB.xid cogenic mice. J Immunol 1982;128:1414-19.
75. Hang LM, Slack JH, Amundson C, Izui S, Theofilopoulos AN, Dixon FJ. Induction of murine autoimmune disease by chronic polyclonal B cell activation. J Exp Med 1983;157:874-83.
76. Granholm NA, Cavallo T. Bacterial lipopolysaccharide enhances deposition of immune complexes and exacerbates nephritis in BXSB lupus-prone mice. Clin Exp Immunol 1991; 85:270-7.
77. Madrenas J, Wange RL, Wang JL, Isakov N, Samelson LE, Germain RN. Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists. Science 1995; 267:515-18.
78. Cyster JG, Hartley SB, Goodnow CC. Competition for follicular niches excludes self-reactive cells from the recirculating B cell repertoire. Nature 1995;371:389-95.